Here are relevant reports on : smart-contract-market
-
Diagnostic Contract Manufacturing Market by Device (In Vitro Diagnostic Devices and Diagnostic Imaging Devices), Service (Device Development & Manufacturing, Quality Management, and Packaging & Assembly), Application, Region - Global Forecast to 2028
The global diagnostic contract manufacturing market, valued at US$23.3 billion in 2022, stood at US$26.0 billion in 2023 and is projected to advance at a resilient CAGR of 11.5% from 2023 to 2028, culminating in a forecasted valuation of US$44.9 billion by the end of the period. The growth in this market is attributed to the rising number of diagnostic public-private partnerships, and government grants will increase the use of medical devices in emerging countries, leading to a boom in contract manufacturing.
- Published: April 2024
- Price: $ 4950
- TOC Available:
-
Protein Binding Assays Market by Technology (Equillibrium Dialysis, Ultrafiltration, Ultracentrifugation, Gel Filtration Chromatography), End User (Pharmaceutical & Biotechnology Companies, Contract Research Organization) - Global Forecast to 2023
The major players operating in the global protein binding assay market are Thermo Fisher (US), HTDialysis (US), Merck (US), GE Healthcare (US), and Absorption Systems (US). The global protein binding market is projected to reach USD 425.7 million in 2023 from USD 256.1 million in 2018, at a CAGR of 10.7%. The growing number of drug discovery activities, the minimizing drug discovery and development costs, and the increase in pharmaceutical R&D expenditure are driving the growth of this market. The key players in the global protein binding assays market are HTDialysis (US), Thermo Fisher Scientific (US), Merck (Germany), and Sovicell (Germany).
- Published: August 2018
- Price: $ 4950
- TOC Available:
-
Filter Integrity Test Market by Test Type (Bubble Point, Diffusion, Water Flow), Mechanism (Manual, Automation), Filter Type (Air, Liquid), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, Academics) - Global Forecast to 2024
The Filter Integrity Test Market is projected to reach USD 79 million by 2024, growing at a CAGR of 5.0%. Factors such as increasing R&D spending, growth in the biopharmaceutical industry, and increasing purity requirements in the end-user market are driving the growth of the filter integrity test market. The major players in the filter integrity test market are Merck KGaA (Germany), Danaher Corporation/Pall Corporation (US), Sartorius (Germany), Donaldson Company (US), Parker Hannifin Corporation (US), Meissner Filtration Product (US), MDI Filtration Technologies (US), Thermo Fisher Scientific (US), Eaton Corporation (Ireland), and SH-Surway (China).
- Published: February 2019
- Price: $ 4950
- TOC Available:
-
Medical Device Manufacturing Equipment (by Production) Market by Type (Material Processing, Sterilization & Cleaning Equipment), Application (Consumables & Disposables), End User (OEMs, Contract Manufacturing Organizations) - Global Forecast to 2030
The global medical device manufacturing equipment (by production) market, valued at US$18.0 billion in 2024, stood at US$19.24 billion in 2025 and is projected to advance at a resilient CAGR of 7.0% from 2025 to 2030, culminating in a forecasted valuation of US$27.80 billion by the end of the period. The medical device manufacturing equipment (by production) market is driven by advancements in automation, robotics, and precision machining, along with increasing demand for high-quality, regulatory-compliant devices.
- Published: September 2025
- Price: $ 4950
- TOC Available:
-
Veterinary Contract Manufacturing & Research Market by Service (Discovery, API Development, Regulatory Affairs, Consulting, Packaging & Labeling), Product (API, Fill-Finish, Medical Devices), Animal Type (Companion, Livestock) - Global Forecast to 2031
The Veterinary Contract Manufacturing & Research market, valued at USD 5.92 billion in 2025, stood at USD 6.38 billion in 2026 and is projected to advance at a resilient CAGR of 7.7% from 2026 to 2031, culminating in a forecasted valuation of USD 9.24 billion by the end of the period. The market growth is driven by rising outsourcing of drug development and manufacturing, growing demand for advanced veterinary therapeutics such as biologics and vaccines, and the rising need for specialized research, testing, and GMP-compliant production capabilities.
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
IVD Contract Manufacturing Market by Device Type (Consumables, Equipment), Technology (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation), Service (Manufacturing, Assay Development) - Global Forecast to 2028
The global IVD contract manufacturing market, valued at US$14.2 billion in 2022, stood at US$15.4 billion in 2023 and is projected to advance at a resilient CAGR of 11.5% from 2023 to 2028, culminating in a forecasted valuation of US$26.7 billion by the end of the period. Growth in this market can primarily be attributed to the growing need for less costly and better equipment's, increased need for IVD OEMs to establish themselves in the high potential market and emerge as a budding player in other allied markets, reduced risk of development failure, and reduction in cross contamination of IVD consumables at the CMO facility, and emergence of small scaled outsourcing facilities in emerging nations.
- Published: June 2023
- Price: $ 4950
- TOC Available:
-
Legal AI Software Market by Offering (Legal AI Platforms, Generative AI Agents, Legal Drafting Tools, Report Generation Tools), Application (Ediscovery, Legal Research & Analytics, Contract Drafting & Review, IP Management) - Global Forecast to 2030
The legal AI software market is expected to grow from USD 3.11 billion in 2025 to USD 10.82 billion by the year 2030, at a CAGR of 28.3% during the forecast period. The major players in the legal AI software market include LexisNexis (US), Thomson Reuters (Canada), Sirion (US), Wolters Kluwer (Netherlands), Relativity (US), CS DISCO (US), and Consilio (US), along with SMEs and startups such as Harvey (US), vLex (US), Lawgeex (US), Neota Logic (US), and eBrevia (US).
- Published: February 2025
- Price: $ 4950
- TOC Available:
-
Contract Management Software Market by Component (Software and Services), Business Function (Legal, Sales, Procurement, and Finance), Deployment Type (On-premises and Cloud), Organization Size, Vertical, and Region - Global Forecast to 2024
Contract management software market is expected to grow USD 2.9 billion by 2024, at a Compound Annual Growth Rate (CAGR) of 13.5% during the forecast period. Key and emerging market players include Aaveneir (US), Agiloft (US), Apptus (US), CLM Matrix (US), CobbleStone Software (US), Conga (US), Concord (US), ContractWorks (US), ContractsWise (UK), Coupa (US), Determine (US), DocuSign (US), IBM (US), Icertis (US), GEP (US), HighQ (UK), JAGGAER (US), SAP Ariba (US), Synertrade (France), Trackado (Sweden), and Zycus (US). These players have adopted various strategies to grow in the contract management software market.
- Published: October 2019
- Price: $ 4950
- TOC Available:
-
Drug Discovery Informatics Market by Function (Target Data, Sequencing Data Analysis, Docking), Solution (Software, Services), Application (Drug Development), End User (Pharmaceutical, Biotechnology, Contract Research Organizations) & Region - Global Forecast to 2025
The global drug discovery informatics market growth is primed to transition from $2.2 billion in 2020 to $3.5 billion by 2025, showcasing a strong CAGR of 9.3%. The market is primarily driven by increased R&D spending, especially in rare diseases, and the growing adoption of informatics in drug discovery.
- Published: April 2020
- Price: $ 4950
- TOC Available:
-
CRISPR Market by Product Type (Plasmids, Vectors, CAS9 Nuclease & GRNA, Delivery System), Application (Genetic Engineering, Cell Engineering) & End User (Biotechnology & Pharmaceutical Companies, Contract Research Organization) - Global Forecast to 2023
The global CRISPR market is expected to reach USD 4.16 billion by 2023 from USD 2.01 billion in 2018, growing at a CAGR of 15.7%. Increasing incidences and prevalence of genetic disorders, rising government funding on genomic research, increasing production of genetically modified crops and increasing demand for drug discovery are some of the major factors driving the growth of the global CRISPR market.
- Published: May 2026
- Price: $ 4950
- TOC Available:
Records 41 to 50 of 50
